Matches in Wikidata for { <http://www.wikidata.org/entity/Q91048547> ?p ?o ?g. }
Showing items 1 to 49 of
49
with 100 items per page.
- Q91048547 description "article scientifique publié en 2019" @default.
- Q91048547 description "artículu científicu espublizáu en xineru de 2019" @default.
- Q91048547 description "im Januar 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q91048547 description "scientific article published on 14 January 2019" @default.
- Q91048547 description "wetenschappelijk artikel" @default.
- Q91048547 description "наукова стаття, опублікована 14 січня 2019" @default.
- Q91048547 name "Anti-secretogranin III therapy of oxygen-induced retinopathy with optimal safety" @default.
- Q91048547 name "Anti-secretogranin III therapy of oxygen-induced retinopathy with optimal safety" @default.
- Q91048547 type Item @default.
- Q91048547 label "Anti-secretogranin III therapy of oxygen-induced retinopathy with optimal safety" @default.
- Q91048547 label "Anti-secretogranin III therapy of oxygen-induced retinopathy with optimal safety" @default.
- Q91048547 prefLabel "Anti-secretogranin III therapy of oxygen-induced retinopathy with optimal safety" @default.
- Q91048547 prefLabel "Anti-secretogranin III therapy of oxygen-induced retinopathy with optimal safety" @default.
- Q91048547 P1433 Q91048547-55CBAED7-C2FC-48A9-A744-4B326274463E @default.
- Q91048547 P1476 Q91048547-41D9C703-B035-4597-A28E-F472A55BB3D5 @default.
- Q91048547 P2093 Q91048547-21FC5A6D-1C7F-4B31-8572-996D52F8484B @default.
- Q91048547 P2093 Q91048547-24BB1084-5464-4832-B4E2-3E28B39C2C02 @default.
- Q91048547 P2093 Q91048547-560D522F-38B5-4D2D-B8A9-6C59884A7F0A @default.
- Q91048547 P2093 Q91048547-89115DF4-9692-4C93-9DB0-FAD52935C2C9 @default.
- Q91048547 P2093 Q91048547-892E3E3A-144F-4D05-9A4F-FD5FB9C820B4 @default.
- Q91048547 P2093 Q91048547-F40F3B25-09C5-4312-A168-ACABE804B9BA @default.
- Q91048547 P2093 Q91048547-FB4377B2-2B26-4D14-961B-BEF431AD3CAB @default.
- Q91048547 P304 Q91048547-01AFFB91-AF59-4359-9404-E6C93FD38D7E @default.
- Q91048547 P31 Q91048547-9FCED40A-09EE-4DBC-AC71-09E50623C531 @default.
- Q91048547 P356 Q91048547-4E24B694-C2A2-4FD3-9DB4-B6A6743709BF @default.
- Q91048547 P433 Q91048547-997712FA-FDF5-46DA-9FCA-D1E58B162435 @default.
- Q91048547 P478 Q91048547-0B47ECD5-B7D9-44A6-824B-A4353F06D99D @default.
- Q91048547 P50 Q91048547-892A5A7B-E4D4-4F87-A2BE-2AA066EFE3D6 @default.
- Q91048547 P577 Q91048547-280FCDCB-05EA-4467-8966-ECEBE7B24891 @default.
- Q91048547 P698 Q91048547-00198DAF-0E22-4DF1-B7CA-D3A0E78D00C1 @default.
- Q91048547 P356 S10456-019-09662-4 @default.
- Q91048547 P698 30644010 @default.
- Q91048547 P1433 Q15753544 @default.
- Q91048547 P1476 "Anti-secretogranin III therapy of oxygen-induced retinopathy with optimal safety" @default.
- Q91048547 P2093 "Dan Liang" @default.
- Q91048547 P2093 "Fen Tang" @default.
- Q91048547 P2093 "Hong Tian" @default.
- Q91048547 P2093 "Michelle E LeBlanc" @default.
- Q91048547 P2093 "Ping Chen" @default.
- Q91048547 P2093 "Tsung-Han Chou" @default.
- Q91048547 P2093 "Weiwen Wang" @default.
- Q91048547 P304 "369-382" @default.
- Q91048547 P31 Q13442814 @default.
- Q91048547 P356 "10.1007/S10456-019-09662-4" @default.
- Q91048547 P433 "3" @default.
- Q91048547 P478 "22" @default.
- Q91048547 P50 Q87926890 @default.
- Q91048547 P577 "2019-01-14T00:00:00Z" @default.
- Q91048547 P698 "30644010" @default.